Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Pierre M. J. Zelissen"'
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Pp 1-4 (2016)
In this report, we describe a female patient with both prolactinoma and psychotic disorder who was successfully treated with aripiprazole, a partial dopamine 2 receptor agonist. During the follow-up of more than 10 years, her psychotic symptoms impro
Externí odkaz:
https://doaj.org/article/24ab8e407a164747a6490519c72c76a8
Autor:
Robert D, Murray, Bertil, Ekman, Sharif, Uddin, Claudio, Marelli, Marcus, Quinkler, Pierre M J, Zelissen, Christof, Schoefl
Publikováno v:
Clinical Endocrinology, 86(3), 340-346. Wiley
Context and objectiveTreatment for adrenal insufficiency (AI) remains suboptimal. Despite glucocorticoid replacement, patients with AI have reduced life expectancy and quality of life. This study aimed to describe the spectrum of management of glucoc
Autor:
Marieke de Vries, Janine H. Stubbe, Lisanne C C J Smans, Ad R. M. M. Hermus, H. Hofstetter, Pierre M. J. Zelissen, Frank J G Backx, Eline S. van der Valk
Publikováno v:
Clinical endocrinology, 85(3), 354-60. Wiley-Blackwell
Clinical Endocrinology, 3, 85, 354-360
Clinical Endocrinology, 85, 3, pp. 354-60
Clinical Endocrinology, 85(3), 354. Wiley-Blackwell
Clinical Endocrinology, 85, 354-60
Clinical Endocrinology, 3, 85, 354-360
Clinical Endocrinology, 85, 3, pp. 354-60
Clinical Endocrinology, 85(3), 354. Wiley-Blackwell
Clinical Endocrinology, 85, 354-60
Background: Health-related quality of life in patients with Addison's disease has been assessed in various European countries, indicating a reduced quality of life. However, no studies have addressed the impact of Addison's disease on physical activi
Autor:
Ad R. M. M. Hermus, Jeroen Hendrikse, F. J. Anton Meijer, Peter R. Luijten, Amy Groenewegen, Dik R. Rutgers, Theo D. Witkamp, Pierre M. J. Zelissen, Alexandra A. J. de Rotte, Erik J. van Lindert
Publikováno v:
European Radiology, 26, 1, pp. 271-7
European Radiology, 26, 271-7
European Radiology
European Radiology, 26, 271-7
European Radiology
Objective To evaluate the detection of pituitary lesions at 7.0 T compared to 1.5 T MRI in 16 patients with clinically and biochemically proven Cushing’s disease. Methods In seven patients, no lesion was detected on the initial 1.5 T MRI, and in ni
Autor:
Pierre M. J. Zelissen, Eric Fliers, Ellen Molewijk, Koen M.A. Dreijerink, Dooren Ad van, Maayan Martens, Rob Heerdink
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Autor:
Harm R. Haak, E. P. M. Corssmit, Richard A Feelders, C. W. Menke-van der Houven van Oordt, M. H. T. Ettaieb, Johanna W. Wilmink, Michael Kerstens, Jakob Duker, Pierre M. J. Zelissen, H. J. L. M. Timmers, Bas Havekes
Publikováno v:
Hormones and Cancer, 7(5-6), 336-344. Springer
Hormones and Cancer, 7(5-6), 336-344
Hormones & cancer, 7(5-6), 336-344. Springer US
Europe PubMed Central
Hormones and Cancer, 7(5-6), 336-344. Springer Publishing Company
Hormones and Cancer, 7(5-6), 336-344. SPRINGER
Ettaieb, M H T, Duker, J C, Feelders, R A, Corssmit, E P M, van Oordt, C W M D H, Timmers, H J L M, Kerstens, M N, Wilmink, J W, Zelissen, P M, Havekes, B & Haak, H R 2016, ' Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal Network ', HORMONES & CANCER, vol. 7, no. 5-6, pp. 336-344 . https://doi.org/10.1007/s12672-016-0270-5
Discover Oncology, 7, 5-6, pp. 336-344
HORMONES & CANCER, 7(5-6), 336-344. Springer US
Discover Oncology, 7, 336-344
Hormones and Cancer, 7(5-6), 336-344
Hormones & cancer, 7(5-6), 336-344. Springer US
Europe PubMed Central
Hormones and Cancer, 7(5-6), 336-344. Springer Publishing Company
Hormones and Cancer, 7(5-6), 336-344. SPRINGER
Ettaieb, M H T, Duker, J C, Feelders, R A, Corssmit, E P M, van Oordt, C W M D H, Timmers, H J L M, Kerstens, M N, Wilmink, J W, Zelissen, P M, Havekes, B & Haak, H R 2016, ' Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal Network ', HORMONES & CANCER, vol. 7, no. 5-6, pp. 336-344 . https://doi.org/10.1007/s12672-016-0270-5
Discover Oncology, 7, 5-6, pp. 336-344
HORMONES & CANCER, 7(5-6), 336-344. Springer US
Discover Oncology, 7, 336-344
Contains fulltext : 171585.pdf (Publisher’s version ) (Closed access) Adrenal Cortical Carcinoma (ACC) is a rare malignancy with an incidence of 1.0 per million per year in the Netherlands. Median survival varies according to the European Network f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361518736b07dac1573ea80ed8f8af27
https://cris.maastrichtuniversity.nl/en/publications/c1d5c858-598f-415a-ba20-b454c58e4247
https://cris.maastrichtuniversity.nl/en/publications/c1d5c858-598f-415a-ba20-b454c58e4247
Publikováno v:
European Journal of Endocrinology
BackgroundConventional glucocorticoid (GC) replacement for patients with adrenal insufficiency (AI) is inadequate. Patients with AI continue to have increased mortality and morbidity and compromised quality of life despite treatment and monitoring.Ob